drugset / Trial / NCT03656705
CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this clinical investigation is to evaluate the safety and effects of CCCR-modified NK92(CCCR-NK92)infusions in previously treated advanced non-small cell lung carcinoma(NSCLC).
Timeline
- Start
- 2018-09-29
- Primary completion
- 2020-11-30
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CCCR-NK92 cells | Cell therapy | 1e+07 cells | Intravenous |
| Subject | CCCR-NK92 cells | Cell therapy | 1e+08 cells | Intravenous |